General F.D.A. Panel’s Vote on Peptides Raises Concerns About a Prescribing BoomBy Healthcare Propulsion StaffJuly 24, 20260 A Food and Drug Administration advisory panel recommended broader use of six unproven peptides, raising concerns that wellness and telehealth…
Research US FDA advisers weigh restrictions on seven peptides as industry presses for expansionBy Healthcare Propulsion StaffJuly 24, 20260 A panel of advisers to the U.S. Food and Drug Administration on Thursday began weighing whether it should loosen regulations…
General What to Know About Peptides the FDA Is Considering for UseBy Healthcare Propulsion StaffJuly 24, 20260 An advisory committee to the Food and Drug Administration convened Thursday to evaluate whether compounding pharmacies should be allowed to…
